Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 37(1): 85-93, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35923080

ABSTRACT

This study aimed to examine the relationship between epilepsy and COX/5-LOX inflammation pathways in the penicillin and pentylenetetrazole (PTZ)-induced epilepsy models. For this purpose, 42 albino male Wistar rats were used in this study. In the penicillin and PTZ-induced epilepsy models, epileptiform activity was induced by injection of penicillin (500 IU, i.c.) and PTZ (35 mg/kg, i.p., three times a week), respectively. Licofelone (20 mg/kg, i.p.), a dual inhibitor of COX/5-LOX, and esculetin (20 mg/kg, i.p.), a 5-LOX inhibitor, were given. In the penicillin-induced epilepsy model, ECoG activity was recorded for 180 min. In the PTZ-induced epilepsy model, both ECoG activity was recorded, and behavioral parameters were performed. In the penicillin groups, both licofelone and esculetin decreased the mean spike frequency and amplitude during the experiments. In the PTZ groups, licofelone (20 mg/kg, i.p.) was more effective than esculetin (20 mg/kg, i.p.). Licofelone showed its protective effects both in ECoG activity and in behavioral parameters. Esculetin was less effective when compared to licofelone. The electrophysiological and behavioral data from the present study indicated that inflammation pathways might have a crucial role in controlling epileptiform activity in rats. Licofelone might be a valuable candidate in advanced studies.


Subject(s)
Epilepsy , Pentylenetetrazole , Rats , Animals , Pentylenetetrazole/toxicity , Rats, Wistar , Penicillins/adverse effects , Epilepsy/chemically induced , Epilepsy/drug therapy , Disease Models, Animal
2.
Anticancer Drugs ; 33(1): 11-18, 2022 01 01.
Article in English | MEDLINE | ID: mdl-34348356

ABSTRACT

Mucositis is a common side effect of cancer therapies and transplant conditioning regimens. Management of mucositis involves multiple approaches from oral hygiene, anti-inflammatory, anti-apoptotic, cytoprotective, and antioxidant agents, to cryo-therapy, physical therapy, and growth factors. There is room for novel, affordable treatment options, or improvement of currently available therapies. Vitamin D has been shown to regulate mucosa-resident cell populations such as Th17 or innate lymphoid cells and critical mucosal cytokine IL-22; however, their therapeutic potential has not been put to test in preclinical mouse models. In this study, we aimed to test the therapeutic potential of vitamin D injections and IL-22 overexpression in a murine model of chemotherapy-induced mucositis. Balb/c mice were given daily intraperitoneal injections of vitamin D. Mucositis was induced by methotrexate. Another group received IL-22 plasmid via hydrodynamic gene delivery. Weight loss and intestinal histopathology, intestinal levels of cytokines IL-22, IL-17A, GM-CSF, IL-23, IFN-γ, TNF-α, and IL-10, and number of intestinal lamina propria B cell, neutrophil, and total innate lymphoid cells were quantified. Daily vitamin D injections ameliorated intestinal inflammation and elevated intestinal IL-22 levels compared with control groups. Temporal overexpression of IL-22 by hydrodynamic gene delivery slightly increased intestinal IL-22 but failed to confer significant protection from mucositis. To our knowledge, this is the first experimental demonstration in an animal model of mucositis of therapeutic use of vitamin D and IL-22 supplementation and our results with vitamin D suggest it may have merit in further trials in human mucositis patients.


Subject(s)
Inflammation Mediators/metabolism , Interleukins/pharmacology , Intestinal Mucosa/drug effects , Mucositis/pathology , Vitamin D/pharmacology , Animals , Disease Models, Animal , Drug Therapy, Combination , Gene Transfer Techniques , Interleukins/administration & dosage , Methotrexate/pharmacology , Mice , Mice, Inbred BALB C , Mucositis/chemically induced , Vitamin D/administration & dosage , Weight Loss/drug effects , Interleukin-22
3.
Int J Neurosci ; 129(7): 687-697, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30523733

ABSTRACT

OBJECTIVE: This study was aimed at examining the epileptiform activity of the 5-HT2 serotonin receptor agonist and antagonist, and 5-hydroxytryptophan (5-HTP) in penicillin-induced epilepsy in albino Wistar rats. METHODS: For this purpose, 90 albino male Wistar rats were used in this study. Epileptiform activity was induced by an injection of penicillin, an agonist of GABAA receptor, (500 IU, i.c.) into the somatomotor cortex. Thirty minutes after the injection of penicillin, 2,5-dimethoxy-4-iodoamphetamine (DOI, an agonist of 5-HT2 receptor) (0.5, 1, 2 and 4 mg/kg, i.p.), methysergide, an antagonist of 5-HT2 receptor, (1, 10, 20, 50 and 100 µM, i.c.v.) and 5-HTP, precursor of 5-HT, (25, 50, 75 and 100 mg/kg, i.p.) were administered, respectively. RESULTS: DOI, at the doses of 1 and 2 mg/kg, significantly decreased penicillin-induced epileptiform activity (p < 0.05). Methysergide, at the doses of 20, 50 and 100 µM, significantly increased the mean spike frequency of penicillin-induced epileptiform activity (p < 0.05). The doses of 50, 75 and 100 mg/kg of 5-HTP decreased the mean spike frequency of penicillin-induced epileptiform activity (p < 0.05). The mean of amplitude of penicillin-induced epileptiform activity did not significantly change in any of the groups (p > 0.05). CONCLUSION: The electrophysiological data from the present study suggest that serotonin 5-HT2 receptors have an important role in controlling penicillin-induced epileptiform activity in the rat.


Subject(s)
Brain/physiopathology , Epilepsy/physiopathology , Penicillins/administration & dosage , Receptors, Serotonin, 5-HT2/physiology , Serotonin/physiology , 5-Hydroxytryptophan/administration & dosage , Amphetamines/administration & dosage , Animals , Brain/drug effects , Epilepsy/chemically induced , GABA Agonists/administration & dosage , Male , Methysergide/administration & dosage , Rats, Wistar , Serotonin 5-HT2 Receptor Agonists , Serotonin 5-HT2 Receptor Antagonists/administration & dosage , Somatosensory Cortex/drug effects
4.
Pharmacol Rep ; 70(5): 885-889, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30092418

ABSTRACT

BACKGROUND: The most common headache associated with epilepsy occurs after seizure activity and is called a postictal headache. Therefore, the objective of this study was to investigate the effects of low and high doses acetylsalicylic acid (aspirin) on a penicillin-induced experimental epilepsy model. METHODS: Adult male Wistar rats (n = 28, weighing 220 ±â€¯40 g) were used in the experiments. The rats were divided into four groups as Control, Penicillin, Aspirin 150 mg/kg, Aspirin 500 mg/kg. Seizure activity was triggered by an intracortical injection of penicillin G potassium (500 IU/2.5 µl) into the sensory motor cortex. An electrocorticogram was recorded by using conductive screw electrodes. Aspirin at the doses of 500 mg/kg and 150 mg/kg was given intraperitoneally (ip) 30 min after penicillin administration. RESULTS: Anticonvulsant activity appeared at the 30th and 40th min after an intracortically administered injection of penicillin in the groups given aspirin doses of 500 mg/kg (ip) and 150 mg/kg (ip) respectively. The amplitude of epileptiform activity at both doses of aspirin decreased but the difference was not statistically significant. CONCLUSIONS: The results of the present study suggest that low and high doses of aspirin may decrease epileptiform activity in penicillin-induced epilepsy. Aspirin might be suggested for headache associated with epilepsy.


Subject(s)
Aspirin/pharmacology , Epilepsy/chemically induced , Epilepsy/prevention & control , Penicillin G , Animals , Dose-Response Relationship, Drug , Electrocorticography , Male , Rats
5.
Acta Neurobiol Exp (Wars) ; 77(1): 45-56, 2017.
Article in English | MEDLINE | ID: mdl-28379215

ABSTRACT

Traditionally, Morus rubra L. (Moraceae) (red mulberry) and Cornus mas L. (Cornacea) (cornelian cherry) fruits are eaten fresh and are also used in marmalades, juices, jam, natural dyes in Turkey and are believed to have beneficial effects in case of multiple health issues such as antipyretic, diarrhea and intestinal parasites. However, the effects of M. rubra and C. mas on epilepsy has not been known. This study evaluates the effects of M. rubra and C. mas extracts on penicillin-induced epileptiform activity. Sixty Wistar rats randomly divided into ten groups (n=6): control, sham, penicillin, penicillin+M. rubra extract (2.5, 5, 10, 20 mg/kg) and penicillin+C. mas extract (2.5, 5, 10 mg/kg). Epileptiform activity was induced by using penicillin (500 IU, i.c.) and electrocorticogram records (150 min) were obtained. Also, biochemical analysis in blood samples were evaluated. According to the electrocorticogram analysis, the effective dose was detected as 10 mg/kg for both C. mas and M. rubra. This dose decreased the spike frequencies of convulsions while amplitude wasn't changed by both substances. In erythrocyte studies, there were significant differences regarding nitric oxide in the control, sham and penicillin groups. There were significant differences regarding malondialdehyde in all groups. In the plasma, there were significant differences among groups regarding xanthine oxidase in the penicillin­C. mas and penicillin­M. rubra groups. There were differences regarding malondialdehyde in the penicillin-C. mas and M. rubra-C. mas groups. Both extracts reduced the frequency of epileptiform activity. After administration of the extracts malondialdehyde levels decreased also in both erythrocytes and plasma.


Subject(s)
Epilepsy/drug therapy , Erythrocytes/metabolism , Glucosides/chemistry , Morus/chemistry , Plant Extracts/therapeutic use , Pyrans/chemistry , Action Potentials/drug effects , Animals , Anti-Bacterial Agents/toxicity , Anticonvulsants/therapeutic use , Brain Waves/physiology , Cerebral Cortex/pathology , Disease Models, Animal , Epilepsy/blood , Epilepsy/chemically induced , Erythrocytes/drug effects , Male , Neurons/drug effects , Nitric Oxide/blood , Penicillins/toxicity , Rats , Rats, Wistar , Superoxide Dismutase/blood , Thiazolidinediones/blood , Time Factors
6.
Brain Res Bull ; 130: 42-46, 2017 04.
Article in English | MEDLINE | ID: mdl-28017780

ABSTRACT

PURPOSE: The effects of COX-2 inhibitors on seizure activity are controversial. The aim of the current study was to determine the post-treatment effect of aceclofenac on penicillin-induced experimental epilepsy. METHODS: Male Wistar rats were used in all experiments (n=18). The seizure activity was triggered by penicillin (i.c.). Aceclofenac was injected intraperitoneally at doses of 10mg/kg and 20mg/kg. RESULTS: Intraperitoneal administration of 10 and 20mg/kg aceclofenac doses, exhibited proconvulsant properties on seizure activity on rats. The mean spike frequency and amplitude of aceclofenac 10mg/kg were 41.89±2.12 spike/min and 0.619±0.094mV, respectively. The mean spike frequency and amplitude of aceclofenac 20mg/kg were 35.26±2.72 spike/min and 0.843±0.089mV, respectively. CONCLUSION: The results indicated that not all of the COX-2 inhibitors may have anticonvulsant or proconvulsant features on patients with epilepsy susceptibility and must be used with great care. It was also suggested that not only cyclooxygenase metabolic pathway but also lipoxygenase pathway should be considered together in further detailed studies.


Subject(s)
Anticonvulsants/administration & dosage , Cerebral Cortex/drug effects , Cyclooxygenase 2 Inhibitors/administration & dosage , Diclofenac/analogs & derivatives , Epilepsy/prevention & control , Seizures/prevention & control , Animals , Anticonvulsants/toxicity , Cerebral Cortex/physiopathology , Cyclooxygenase 2 Inhibitors/toxicity , Diclofenac/administration & dosage , Diclofenac/toxicity , Epilepsy/complications , Epilepsy/physiopathology , Male , Penicillins/administration & dosage , Rats, Wistar , Seizures/chemically induced , Seizures/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...